Active experimental inhibition of cancer by corynebacterium parvum.
It has been demonstrated that 5 microgram Corynebacterium parvum (Mérieux, Lyon) applied i.v. once weekly in mice of the strain C 3 H X Swiss Albino F 1 after three pregnancies effectively inhibits tumour growth. At this time those mice are 100% at risk. The appearance of tumours in the treated group is significantly delayed.